US · SSKN
STRATA Skin Sciences, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Horsham, PA 19044
- Website
- strataskinsciences.com
Price · as of 2024-12-31
—
Market cap 7.09M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $55.73 | — |
| Intrinsic Value(DCF) | $1.02 | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $1,415.00 | ||||
| 2011 | $2,410.00 | ||||
| 2012 | $615.00 | ||||
| 2013 | $390.00 | $241.20 | $0.00 | $0.00 | $0.00 |
| 2014 | $152.00 | $644.95 | $0.00 | $0.00 | $0.00 |
| 2015 | $52.50 | $4,936.88 | $866,444.02 | $0.00 | $0.00 |
| 2016 | $29.50 | $1,262.59 | $220,041.21 | $0.00 | $0.00 |
| 2017 | $12.90 | $141.88 | $319.13 | $0.00 | $0.00 |
| 2018 | $32.10 | $43.99 | $0.48 | $0.08 | $0.00 |
| 2019 | $15.30 | $33.80 | $0.21 | $0.03 | $0.00 |
| 2020 | $19.00 | $35.01 | $0.25 | $0.00 | $2.30 |
| 2021 | $14.50 | $36.83 | $0.29 | $0.09 | $0.00 |
| 2022 | $9.80 | $80.22 | $0.14 | $0.00 | $0.00 |
| 2023 | $5.30 | $34.42 | $0.00 | $0.00 | $0.00 |
| 2024 | $2.56 | $55.73 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates STRATA Skin Sciences, Inc.'s (SSKN) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $55.73
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.02
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SSKN | STRATA Skin Sciences, Inc… | $1.70 | 7.09M | +3,178% | -40% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
| ADIL | Adial Pharmaceuticals, In… | $0.33 | 7.26M | — | — | — | — | -1.06 | 3.43 | — | -1.23 | — | 3.43 | 0.00% | — | — | -323.80% | -1052.66% | -269.86% | 0.00 | — | 4.16 | 3.84 | 0.45 | -8695.00% | — | — | -49.65% | -7.09 | -879.58% | 0.00% | 0.00% | 6.62% | -1.23 | -1.47 | — | -18.87 |
| ADXN | Addex Therapeutics Ltd | $8.76 | 6.72M | +7,738% | +15% | +685% | — | 0.71 | 0.52 | 12.45 | -0.37 | — | 0.52 | 100.00% | -681.82% | 1746.04% | 130.39% | -137.95% | 92.11% | 0.00 | -776.78 | 4.42 | 4.19 | 0.71 | -15000.00% | -7495.00% | -3281.00% | -106.85% | -6.70 | -269.11% | 0.00% | 0.00% | 0.00% | -0.63 | -0.32 | 4.27 | -43.82 |
| BMRA | Biomerica, Inc. | $2.58 | 7.4M | +7,094% | -52% | — | — | -1.44 | 1.74 | 1.35 | -1.10 | -0.29 | 1.84 | 9.38% | -96.72% | -93.64% | -92.99% | -191.32% | -65.44% | 0.11 | — | 2.80 | 1.80 | 0.41 | 50000.00% | -192.00% | -2918.00% | -54.28% | -2.21 | -144.43% | 0.00% | 0.00% | 0.00% | -1.01 | -1.34 | 0.98 | -11.52 |
| HSCS | HeartSciences Inc. | $2.90 | 6.52M | +667% | -43% | — | +20,854% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| IINN | Inspira Technologies Oxy … | $0.91 | 23.26M | — | — | — | — | -1.42 | 3.64 | — | -1121.82 | — | 3.64 | 0.00% | — | — | -219.74% | 7.39% | -127.19% | 0.58 | — | 2.02 | 1.71 | 234.68 | -9994.00% | — | -426.00% | -60.68% | -2.78 | -6254.43% | 0.00% | 0.00% | 0.00% | 1104.79 | -1.31 | — | -8.52 |
| MHUA | Meihua International Medi… | $0.24 | 7.52M | +23,099% | +53% | +3,205% | +1,234% | 0.81 | 0.06 | 0.09 | 0.05 | — | 0.06 | 34.36% | 14.77% | 11.19% | 7.10% | 7.91% | 6.05% | 0.05 | 9.50 | 5.26 | 4.80 | -0.51 | -1837.00% | -19.00% | -70159.00% | 165.58% | 0.54 | 10.08% | 0.00% | 0.00% | 2.28% | 0.05 | 0.05 | 0.01 | 2.51 |
| NRSN | NeuroSense Therapeutics L… | $1.05 | 25.87M | — | — | — | — | -2.06 | 8.14 | — | -1.79 | — | 8.14 | 0.00% | — | — | -2880.11% | 388.77% | -263.45% | 0.03 | -31.84 | 2.21 | 1.78 | 0.33 | -3373.00% | — | 2094.00% | -48.23% | -5.09 | 398.04% | 0.00% | 0.00% | 3.84% | -1.79 | -1.75 | — | -11.40 |
| PAVM | PAVmed Inc. | $0.35 | 6.09M | +306,826% | +29,017% | +172,865% | +1,028,629% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
- CEO
- Dolev Rafaeli
- Employees
- 106
- Beta
- 0.25
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.02 ÷ —) − 1 = — (DCF, example).